SCHEMBL3780455

SCHEMBL3780455

O=C(CN1CCN(c2ccc(-c3ccc(OC(F)(F)F)cc3)nn2)CC1)N1CCN(C2CCC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PANK3 Q9H999 3/20 0.50
MAPT P10636 2/20 0.47
TP53 P04637 1/20 0.47
EPHX2 P34913 2/20 0.45
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HRH3 Q9Y5N1 5/20 0.41
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SCD O00767 1/20 0.38
KDM1A O60341 1/20 0.38
MAOB P27338 1/20 0.38
MCHR2 Q969V1 1/20 0.38
MCHR1 Q99705 1/20 0.38
TACR3 P29371 1/20 0.37
KDM4E B2RXH2 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5555542 0.90 PANK3 (0.43) PANK3MAPTEPHX2RAB9ANPC1
SCHEMBL3770163 0.88 HRH3 (0.49) MAPTTP53RAB9AKMT2AHRH3
SCHEMBL3777001 0.88 LMNA (0.44) MAPTRAB9ANPC1MEN1KMT2A
SCHEMBL3771986 0.88 ACHE (0.49) MAPTTP53RAB9AKMT2AHRH3
SCHEMBL3767633 0.87 HRH3 (0.46) MAPTRAB9AKMT2AHRH3ALDH1A1
SCHEMBL3773544 0.87 EPHX2 (0.43) PANK3MAPTEPHX2RAB9AMEN1
SCHEMBL3763141 0.87 ALDH1A1 (0.48) MAPTTP53RAB9ANPC1MEN1
SCHEMBL13006478 0.87 HRH3 (0.46) MAPTRAB9ANPC1HRH3ALDH1A1
SCHEMBL3767452 0.85 LMNA (0.45) PANK3RAB9ANPC1MEN1KMT2A
SCHEMBL3767918 0.85 HRH3 (0.47) PANK3MAPTTP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
WO-2007016496-A2 DIPIPERAZINYL KETONES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 PANK3 548/4885MAPT 1475/4885TP53 3661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.